Medicus Pharma Ltd. (MDCX) stock forecast & analysis
0.1720
NasdaqCM · USD
Up: +0.0015, +0.9%
0.1751Up: +0.0031, +1.8%
1 analysis
- Open
- 0.1622
- Previous close
- 0.1705
- Day range
- 0.1600 – 0.1830
- 52-week range
- 0.1510 – 3.05
- Volume (shares)
- 14.84M
- Net assets
- Not available
- Expense ratio
- Not available
- Shares outstanding
- 63.18M
- P/E ratio
- Not available
- Dividend yield
- Not available
- Beta
- -0.48
- Market cap
- 10.87M
Market Scanner’s AI analysis of Medicus Pharma Ltd. (MDCX), updated September 2026: Medicus Pharma Ltd. (MDCX) faces sustained net losses and increasing debt, alongside bearish technical indicators.
Summary
Medicus Pharma Ltd. (MDCX) faces sustained net losses and increasing debt, alongside bearish technical indicators.
Recent analyses for MDCX indicate a challenging financial and technical landscape. The company has reported consistent net losses, with a significant increase in total debt noted in the latest reporting period. Technically, MDCX exhibits strong bearish momentum, with its stock price trading well below key moving averages and indicators suggesting oversold conditions.
MDCX news & sentiment
News coverage for MDCX was limited, with no specific actionable insights beyond a general mention in a list of active stocks. Broader healthcare sector news showed some positive sentiment and activity, influenced by a strong jobs report.
MDCX technical picture
Technical indicators for MDCX presented a bearish outlook, with the stock price closing significantly below its 50-day and 200-day simple moving averages, indicating a downtrend. Momentum indicators like RSI and MFI were in oversold territory, while the MACD showed a bearish signal, and the price was below the lower Bollinger Band.
Fundamentals
Medicus Pharma Ltd. (MDCX) has consistently reported net losses, with a significant increase in total debt noted in the latest reporting period. Shareholder equity turned negative, while cash levels provided a limited buffer.
Factors discussed — upside
- RSI and MFI in oversold territory suggest potential for a bounce.
Factors discussed — risks
- Consistent net losses reported across fiscal years and recent quarters.
- Significant increase in total debt from March 31, 2026, to June 30, 2026.
- Stock price significantly below 50-day and 200-day SMAs.
- Negative shareholder equity as of December 31, 2025.
- Strong bearish momentum indicated by price changes and MACD.
- Financial performance
- Technical indicators
- Debt levels
- Market sentiment
Summary updated .
MDCX technical indicators
Common technical indicators for MDCX, computed from its daily closing prices.
| Indicator | Value | Reading |
|---|---|---|
| 50-day simple moving average | 0.33 | Price below |
| 10-day exponential moving average | 0.23 | Price below |
| Relative strength index (14-day) | 27.67 | Oversold |
| MACD line (12/26/9) | -0.0312 | Below its signal line |
| Bollinger bands (20-day, 2σ) | 0.18 – 0.36 | Price below the lower band |
Analyses
Recent MDCX.US analyses are locked — sign in to read them or generate a fresh one.
Frequently asked questions
- What is the bull case for Medicus Pharma Ltd.?
- The analyses noted that the Relative Strength Index (RSI) and Money Flow Index (MFI) are in oversold territory, suggesting a potential for a bounce.
- What are the risks for Medicus Pharma Ltd.?
- The company has consistently reported net losses and experienced a significant increase in total debt. The stock price is trading below key moving averages, and shareholder equity has turned negative, indicating strong bearish momentum.
- Is Medicus Pharma Ltd. bullish or bearish?
- Recent AI analyses of Medicus Pharma Ltd. examined factors on both sides. Discussed upside: The analyses noted that the Relative Strength Index (RSI) and Money Flow Index (MFI) are in oversold territory, suggesting a potential for a bounce. Discussed risks: The company has consistently reported net losses and experienced a significant increase in total debt. The stock price is trading below key moving averages, and shareholder equity has turned negative, indicating strong bearish momentum. These are descriptive observations, not a recommendation.
- What is the latest sentiment on Medicus Pharma Ltd.?
- News coverage for MDCX was limited, with no specific actionable insights beyond a general mention in a list of active stocks. Broader healthcare sector news showed some positive sentiment and activity, influenced by a strong jobs report.
- Bundles used
- gemini-low-v2
Run a fresh MDCX.US analysis
Configure the ticker, model bundle and debate depth here — you only sign in at the end, and everything you picked comes with you.
Or sign in to read every MDCX.US report already in the library